Bridgeway Capital Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-23,700
| Closed | -$181K | – | 1381 |
|
|
2020
Q2 | $181K | Sell |
23,700
-30,100
| -56% | -$230K | ﹤0.01% | 1167 |
|
|
2020
Q1 | $332K | Sell |
53,800
-150,000
| -74% | -$926K | 0.01% | 894 |
|
|
2019
Q4 | $2.48M | Sell |
203,800
-6,100
| -3% | -$74.2K | 0.03% | 448 |
|
|
2019
Q3 | $2.42M | Hold |
209,900
| – | – | 0.03% | 431 |
|
|
2019
Q2 | $2.1M | Sell |
209,900
-50,000
| -19% | -$500K | 0.03% | 510 |
|
|
2019
Q1 | $3.35M | Buy |
259,900
+97,900
| +60% | +$1.26M | 0.04% | 347 |
|
|
2018
Q4 | $2.46M | Buy |
162,000
+30,100
| +23% | +$457K | 0.03% | 421 |
|
|
2018
Q3 | $2.64M | Buy |
131,900
+85,000
| +181% | +$1.7M | 0.03% | 538 |
|
|
2018
Q2 | $915K | Hold |
46,900
| – | – | 0.01% | 904 |
|
|
2018
Q1 | $945K | Hold |
46,900
| – | – | 0.01% | 866 |
|
|
2017
Q4 | $621K | Sell |
46,900
-28,600
| -38% | -$379K | 0.01% | 1023 |
|
|
2017
Q3 | $1.39M | Hold |
75,500
| – | – | 0.02% | 718 |
|
|
2017
Q2 | $1.39M | Buy |
75,500
+14,500
| +24% | +$267K | 0.02% | 714 |
|
|
2017
Q1 | $1.38M | Buy |
61,000
+25,000
| +69% | +$564K | 0.02% | 699 |
|
|
2016
Q4 | $1.25M | Hold |
36,000
| – | – | 0.02% | 725 |
|
|
2016
Q3 | $882K | Hold |
36,000
| – | – | 0.01% | 851 |
|
|
2016
Q2 | $861K | Hold |
36,000
| – | – | 0.01% | 837 |
|
|
2016
Q1 | $842K | Hold |
36,000
| – | – | 0.01% | 836 |
|
|
2015
Q4 | $1.09M | Buy |
+36,000
| New | +$1.09M | 0.02% | 720 |
|